John M. Maraganore is a businessperson who has been at the head of 5 different companies. Currently, Dr. Maraganore holds the position of Chief Executive Officer & Director at Alnylam Pharmaceuticals, Inc.
He is also on the board of Biotechnology Innovation Organization (former Chairman), Agios Pharmaceuticals, Inc. (former Chairman) and Tempero Pharmaceuticals, Inc.
John M. Maraganore previously occupied the position of Director at MacroGenics, Inc., Director at Regulus Therapeutics, Inc., Director-Business Development & Market at Biogen, Inc. Director-Market & Business Development at Biogen MA, Inc. and Director-Molecular Biology & Business Development at Biogen Idec, Inc. (North Carolina) (both are subsidiaries of Biogen, Inc.), Strategic Advisor at Longwood Fund Management LLC, Scientist at The Upjohn Co., Partner at Third Rock Ventures GP LP, Scientist at ZymoGenetics, Inc. and Senior VP-Strategic Product Development at Takeda Oncology Co.
He received a doctorate, a graduate degree and an undergraduate degree from The University of Chicago.